These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 626182)

  • 21. Loss maternally derived measles immunity in Argentinian infants.
    Nates SV; Giordano MO; Medeot SI; Martínez LC; Baudagna AM; Naretto E; Garrido P; De Wolff CD
    Pediatr Infect Dis J; 1998 Apr; 17(4):313-6. PubMed ID: 9576386
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Age of measles immunization in tropics.
    Mirchamsy H; Shafyi A; Mahinpour M; Nazari P
    Dev Biol Stand; 1978; 41():191-4. PubMed ID: 572788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful immunization of infants with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response.
    Sabin AB; Flores Arechiga A; Fernández de Castro J; Albrecht P; Sever JL; Shekarchi I
    JAMA; 1984 May; 251(18):2363-71. PubMed ID: 6368888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The duration of maternal measles antibodies in children.
    Kiliç A; Altinkaynak S; Ertekin V; Inandi T
    J Trop Pediatr; 2003 Oct; 49(5):302-5. PubMed ID: 14604165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A REGIMEN FOR IMMUNIZATION AGAINST MEASLES. INACTIVATED VACCINE WITH DPT AND LIVE VACCINE AT AGE 9 MONTHS.
    KARELITZ S; SCHLUEDERBERG A; KANCHANAVATEE P; ARAI M; ACS H
    JAMA; 1965 Mar; 191():1067-70. PubMed ID: 14261887
    [No Abstract]   [Full Text] [Related]  

  • 26. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children.
    Wong-Chew RM; Islas-Romero R; García-García Mde L; Beeler JA; Audet S; Santos-Preciado JI; Gans H; Lew-Yasukawa L; Maldonado YA; Arvin AM; Valdespino-Gómez JL
    Vaccine; 2006 Jan; 24(5):683-90. PubMed ID: 16154241
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Seroconversion after measles vaccination at nine and fifteen months of age.
    Işik N; Uzel N; Gökçay G; Kiliç A; Yilmaz G; Sadikoğlu B; Diri S
    Pediatr Infect Dis J; 2003 Aug; 22(8):691-5. PubMed ID: 12913768
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Booster vaccination with further live attenuated measles vaccine.
    Bass JW; Halstead SB; Fischer GW; Podgore JK; Pearl WR; Schydlower M; Wiebe RA; Ching FM
    JAMA; 1976 Jan; 235(1):31-4. PubMed ID: 945997
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Two-dose measles vaccination schedules.
    Rosenthal SR; Clements CJ
    Bull World Health Organ; 1993; 71(3-4):421-8. PubMed ID: 8324862
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Development of measles vaccination in Austria].
    Huber EG; Rannon L
    Padiatr Padol; 1973; 8(3):247-56. PubMed ID: 4715034
    [No Abstract]   [Full Text] [Related]  

  • 31. Enhancement in seroconversion to measles vaccine with simultaneous administration of vitamin A in 9-months-old Indian infants.
    Bhaskaram P; Rao KV
    Indian J Pediatr; 1997; 64(4):503-9. PubMed ID: 10771879
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Serological evaluation of immunization against measles with 2 doses administered at 6 and 11 months of age: a prospective study].
    Pannuti CS; de Souza VA; Sato HK; Fink MC; Ribeiro MI; Hisi SK; Castelo A; de Mendonça JS
    Rev Inst Med Trop Sao Paulo; 1990; 32(6):450-5. PubMed ID: 2135492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antibody response to measles immunization in rural Ghanaian infants.
    Sakatoku H; Nakano T; Arai S; Afari EA
    J Trop Pediatr; 1994 Oct; 40(5):291-3. PubMed ID: 7807624
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous administration of live attenuated measles vaccine with DTP vaccine.
    McBean AM; Gateff C; Manclark CR; Foster SO
    Pediatrics; 1978 Sep; 62(3):288-93. PubMed ID: 704197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibody response after measles immunization.
    Ariyasriwatana C; Kalayanarooj S; Pattamadilok S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S701-6. PubMed ID: 14700170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Waning of measles maternal antibody in infants in measles elimination settings - A systematic literature review.
    Guerra FM; Crowcroft NS; Friedman L; Deeks SL; Halperin SA; Severini A; Hatchette TF; Bolotin S;
    Vaccine; 2018 Feb; 36(10):1248-1255. PubMed ID: 29398276
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Humoral and cell-mediated immune responses to an early 2-dose measles vaccination regimen in the United States.
    Gans HA; Yasukawa LL; Alderson A; Rinki M; DeHovitz R; Beeler J; Audet S; Maldonado Y; Arvin AM
    J Infect Dis; 2004 Jul; 190(1):83-90. PubMed ID: 15195246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CHRONOVAC VOYAGEUR: A study of the immune response to yellow fever vaccine among infants previously immunized against measles.
    Goujon C; Gougeon ML; Tondeur L; Poirier B; Seffer V; Desprès P; Consigny PH; Vray M;
    Vaccine; 2017 Oct; 35(45):6166-6171. PubMed ID: 28958813
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disappearance of measles antibody in Thai infants after birth.
    Vanprapar N; Chavalittamrong B; Chearskul S; Pimolpan V
    Southeast Asian J Trop Med Public Health; 1983 Dec; 14(4):488-90. PubMed ID: 6673124
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Optimal age for vaccinating Nigerian children against measles. II. Seroconversion to measles vaccine in different age groups.
    Ogunmekan DA; Harry TO
    Trop Geogr Med; 1981 Dec; 33(4):379-82. PubMed ID: 7342385
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.